
|Articles|November 5, 2015
Pediatric Drug Development & Therapeutics
Author(s)DIA
Advertisement
DIA’s Editor-in-Chief Stephen P. Spielberg, MD, PhD, FAAP, and Ronald Portman, MD, FAAP, discuss the Pediatric Drug Development & Therapeutics series of articles and how they can help inform the future of pediatric drug development on DIA’s podcast channel,
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Regeneron Focusing on Broad Pipeline Development
2
What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan Healthcare Conference?
3
Novartis Calls for Global Governments to Address Global Trade Policy
4
President Trump Asks Congress to Enact 'The Great Healthcare Plan:' Report
5




